88 related articles for article (PubMed ID: 7132559)
1. Conformational preferences of dopamine analogues for inhibition of norepinephrine N-methyltransferase. Conformationally defined adrenergic agents.
Grunewald GL; Pleiss MA; Rafferty MF
Life Sci; 1982 Sep; 31(10):993-1000. PubMed ID: 7132559
[TBL] [Abstract][Full Text] [Related]
2. Conformational and steric aspects of phenylethanolamine and phenylethylamine analogues as substrates or inhibitors of phenylethanolamine N-methyltransferase.
Grunewald GL; Ye Q; Sall DJ; Criscione KR; Wise B
Mol Pharmacol; 1989 Jan; 35(1):93-7. PubMed ID: 2913486
[TBL] [Abstract][Full Text] [Related]
3. Binding orientation of amphetamine and norfenfluramine analogues in the benzonorbornene and benzobicyclo[3.2.1]octane ring systems at the active site of phenylethanolamine N-methyltransferase (PNMT).
Grunewald GL; Markovich KM; Sall DJ
J Med Chem; 1987 Dec; 30(12):2191-208. PubMed ID: 3681889
[TBL] [Abstract][Full Text] [Related]
4. Conformational requirements of substrates for activity with phenylethanolamine N-methyltransferase.
Grunewald GL; Ye Q; Kieffer L; Monn JA
J Med Chem; 1988 Jan; 31(1):169-71. PubMed ID: 3336016
[TBL] [Abstract][Full Text] [Related]
5. Conformationally restricted and conformationally defined tyramine analogues as inhibitors of phenylethanolamine N-methyltransferase.
Ye QH; Grunewald GL
J Med Chem; 1989 Feb; 32(2):478-86. PubMed ID: 2913308
[TBL] [Abstract][Full Text] [Related]
6. Conformational and steric aspects of the inhibition of phenylethanolamine N-methyltransferase by benzylamines.
Grunewald GL; Sall DJ; Monn JA
J Med Chem; 1988 Feb; 31(2):433-44. PubMed ID: 3339613
[TBL] [Abstract][Full Text] [Related]
7. Importance of the aromatic ring in adrenergic amines. 8. 2-(Aminomethyl)-trans-2-decalols as inhibitors of norepinephrine N-methyltransferase.
Rafferty MF; Krass P; Borchardt RT; Grunewald GL
J Med Chem; 1982 Oct; 25(10):1250-2. PubMed ID: 7143367
[TBL] [Abstract][Full Text] [Related]
8. The remarkable substrate activity for phenylethanolamine N-methyltransferase of some conformationally defined phenylethylamines lacking a side-chain hydroxyl group. Conformationally defined adrenergic agents. 6.
Rafferty MF; Grunewald GL
Mol Pharmacol; 1982 Jul; 22(1):127-32. PubMed ID: 7121446
[No Abstract] [Full Text] [Related]
9. Binding requirements of phenolic phenylethylamines in the benzonorbornene skeleton at the active site of phenylethanolamine N-methyltransferase.
Grunewald GL; Arrington HS; Bartlett WJ; Reitz TJ; Sall DJ
J Med Chem; 1986 Oct; 29(10):1972-82. PubMed ID: 3761316
[TBL] [Abstract][Full Text] [Related]
10. Norepinephrine N-methyltransferase inhibition by benzamidines, phenylacetamidines, benzylguanidines, and phenylethylguanidines.
Fuller RW; Roush BW; Snoddy HD; Day WA; Molloy BB
J Med Chem; 1975 Mar; 18(3):304-7. PubMed ID: 1133822
[TBL] [Abstract][Full Text] [Related]
11. Conformational preferences of amphetamine analogues for inhibition of phenylethanolamine N-methyltransferase. Conformationally defined adrenergic agents. 5.
Grunewald GL; Borchardt RT; Rafferty MF; Krass P
Mol Pharmacol; 1981 Sep; 20(2):377-81. PubMed ID: 7300818
[No Abstract] [Full Text] [Related]
12. 3,7-Disubstituted-1,2,3,4-tetrahydroisoquinolines display remarkable potency and selectivity as inhibitors of phenylethanolamine N-methyltransferase versus the alpha2-adrenoceptor.
Grunewald GL; Dahanukar VH; Teoh B; Criscione KR
J Med Chem; 1999 Jun; 42(11):1982-90. PubMed ID: 10354406
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 3-substituted analogues of 1,2,3,4-tetrahydroisoquinoline as inhibitors of phenylethanolamine N-methyltransferase.
Grunewald GL; Sall DJ; Monn JA
J Med Chem; 1988 Apr; 31(4):824-30. PubMed ID: 3351861
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of norepinephrine N-methyltransferase by 1-aminoindans, conformationally rigid analogs of benzylamines.
Fuller RW; Roush BW; Hemrick SK; Snoddy HD; Molloy BB
Life Sci; 1978 Apr; 22(16):1421-7. PubMed ID: 672406
[No Abstract] [Full Text] [Related]
15. Importance of the aromatic ring in adrenergic amines. 7. Comparison of the stereoselectivity of norepinephrine N-methyltransferase for aromatic vs. nonaromatic substrates and inhibitors.
Rafferty MF; Wilson DS; Monn JA; Krass P; Borchardt RT; Grunewald GL
J Med Chem; 1982 Oct; 25(10):1198-204. PubMed ID: 7143356
[TBL] [Abstract][Full Text] [Related]
16. Studies on adrenal phenylethanolamine N- methyltransferase (PNMT) with S K & F 64139, a selective inhibitor.
Pendleton RG; Kaiser C; Gessner G
J Pharmacol Exp Ther; 1976 Jun; 197(3):623-32. PubMed ID: 6786
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of phenylethanolamine N-methyltransferase (PNMT) by aromatic hydroxy-substituted 1,2,3,4,-tetrahydroisoquinolines: further studies on the hydrophilic pocket of the aromatic ring binding region of the active site.
Sall DJ; Grunewald GL
J Med Chem; 1987 Dec; 30(12):2208-16. PubMed ID: 3681890
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of phenylethanolamine N-methyltransferase and epinephrine biosynthesis. 3. Bis[tetrahydroisoquinoline]s.
DeMarinis RM; Bryan WM; Hillegass LM; McDermott D; Pendleton RG
J Med Chem; 1981 Jun; 24(6):756-9. PubMed ID: 7252985
[TBL] [Abstract][Full Text] [Related]
19. The interaction of rabbit adrenal norepinephrine N-methyl transferase isozymes with substrates.
Lee HS; Schulz AR; Fuller RW
Arch Biochem Biophys; 1978 Jan; 185(1):228-38. PubMed ID: 623486
[No Abstract] [Full Text] [Related]
20. Effects of phenylethanolamine N-methyltransferase inhibitors on uptake and release of norepinephrine and dopamine from rat brain.
Liang NY; Hower JA; Borchardt RT
Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):467-70. PubMed ID: 4059661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
